13D Filing: Scopia Capital Reveals Big Stake in Conmed Corp (CNMD)

The aggregate purchase price of the 33,666 Shares beneficially owned by Scopia Health is approximately $1,288,085, excluding brokerage commissions.

The aggregate purchase price of the 309,512 Shares beneficially owned by Scopia Windmill is approximately $11,842,153, excluding brokerage commissions.

The aggregate purchase price of the 77,391 Shares beneficially owned by Scopia International is approximately $2,961,036, excluding brokerage commissions.

The aggregate purchase price of the 558,629 Shares beneficially owned by Scopia PX International is approximately $21,373,549, excluding brokerage commissions.

The aggregate purchase price of the 245,043 Shares beneficially owned by Scopia Health International is approximately $9,375,522, excluding brokerage commissions.

The aggregate purchase price of the 22,623 Shares held in the Managed Account is approximately $865,572, excluding brokerage commissions.

Item 5.

Interest in Securities of the Issuer.

Items 5(a) – (d) are hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each person named herein is based upon 27,712,715 Shares outstanding as of February 15, 2016, which is the total number of Shares outstanding as reported in the Issuer’s annual report on Form 10-K filed with the Securities and Exchange Commission on February 23, 2016.

A.

Scopia PX

(a)

As of the close of business on February 22, 2016, Scopia PX beneficially owned 434,231 Shares.

Percentage: Approximately 1.6%

(b)

1. Sole power to vote or direct vote: 434,231

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 434,231

4. Shared power to dispose or direct the disposition: 0

(c)

The transactions in the securities of the Issuer by Scopia PX since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

B.	Scopia Partners

(a)

As of the close of business on February 22, 2016, Scopia Partners beneficially owned 12,261 Shares.

Percentage: Less than 1%

(b)

1. Sole power to vote or direct vote: 12,261

2. Shared power to vote or direct vote: 0

3. Sole power to dispose or direct the disposition: 12,261

4. Shared power to dispose or direct the disposition: 0

(c)

The transactions in the securities of the Issuer by Scopia Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

13D Filing: Scopia Capital Reveals Big Stake in Conmed Corp (CNMD)

Published on February 23, 2016 at 5:52 pm by Meena Krishnamsetty in Hedge Funds, News

Page 16 of 23 SEC Filing

Follow Conmed Corp (NASDAQ:CNMD)

Follow Conmed Corp (NASDAQ:CNMD)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff